Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of γδ T cells expanded from peripheral blood cells by stimulation with zoledronate

References

• Carding SR, Egan PJ. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002; 2: 336–45
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Morita CT, Tanaka Y, et al. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 1995; 375: 155–8
   PubMed Web of Science ®Google Scholar
• Bukowski JF, Morita CT, Brenner MB. Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity 1999; 11: 57–65
   PubMed Web of Science ®Google Scholar
• Kunzmann V, Bauer E, Wilhelm M. Gamma/delta T-cell stimulation by pamidronate. N Engl J Med 1999; 340: 737–8
   PubMed Web of Science ®Google Scholar
• Chen ZW, Letvin NL. Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm. Trends Immunol 2003; 24: 213–9
   PubMed Web of Science ®Google Scholar
• Kunzmann V, Bauer E, Feurle J, et al. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000; 96: 384–92
   PubMed Web of Science ®Google Scholar
• Gober HJ, Kistowska M, Angman L, et al. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003; 197: 163–8
   PubMed Web of Science ®Google Scholar
• Harwood HJJr, Alvarez IM, Noyes WD, et al. In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma. J Lipid Res 1991; 32: 1237–52
   PubMed Web of Science ®Google Scholar
• Asslan R, Pradines A, Pratx C, et al. Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells. Biochem Biophys Res Commun 1999; 260: 699–706
   PubMedGoogle Scholar
• Takahashi M, Narita M, Ayres F, et al. Cytoplasmic expression of EGFP in dendritic cells transfected with in vitro transcribed mRNA or cellular total RNA extracted from EGFP expressing leukemia cells. Med Oncol 2003; 20: 335–48
   PubMedGoogle Scholar
• Osman Y, Narita M, Ayres F, et al. Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA. Cytotherapy 2003; 5: 161–8
   PubMed Web of Science ®Google Scholar
• Furukawa T, Koike T, Ying W, et al. Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis. Leukemia 1994; 8: 171–80
   PubMed Web of Science ®Google Scholar
• Narita M, Takahashi M, Liu A, et al. Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia. Exp Hematol 2001; 29: 709–19
   PubMed Web of Science ®Google Scholar
• Sato K, Kimura S, Segawa H, et al. Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy. Int J Cancer 2005; 116: 94–9
   PubMed Web of Science ®Google Scholar
• Dieli F, Gebbia N, Poccia F, et al. Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. Blood 2003; 102: 2310–11
   PubMed Web of Science ®Google Scholar
• Sicard H, Al Saati T, Delsol G, et al. Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma. Mol Med 2001; 7: 711–22
   PubMed Web of Science ®Google Scholar
• Das H, Wang L, Kamath A, et al. V(2V(2 T-cell receptor-mediated recognition of aminobisphosphonates. Blood 2001; 98: 1616–18
   PubMed Web of Science ®Google Scholar
• Kabelitz D, Wesch D, Pitters E, et al. Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo. J Immunol 2004; 173: 6767–76
   PubMed Web of Science ®Google Scholar
• Kato Y, Tanaka Y, Miyagawa F, et al. Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens. J Immunol 2001; 167: 5092–8
   PubMed Web of Science ®Google Scholar
• Schilbach K, Geiselhart A, Handgretinger R. Induction of proliferation and augmented cytotoxicity of gammadelta T lymphocytes by bisphosphonate clodronate. Blood 2001; 97: 2917–8
   PubMedGoogle Scholar
• Bukowski JF, Dascher CC, Das H. Alternative bisphosphonate targets and mechanisms of action. Biochem Biophys Res Commun 2005; 328: 746–50
   PubMed Web of Science ®Google Scholar
• Kunzmann V, Kretzschmar E, Herrmann T, et al. Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons. Immunology 2004; 112: 369–77
   PubMed Web of Science ®Google Scholar
• Rincon-Orozco B, Kunzmann V, Wrobel P, et al. Activation of Vγ9Vδ2 Tcells by NKG2D. J Immunol 2005; 175: 2144–51
   PubMed Web of Science ®Google Scholar